S HARBOURHOLD (01663) received the main shareholder Chen Xiangling increasing holdings by 9.2 million shares.
Han Harbour Holdings (01663) announced that the Board of Directors has been informed by the company's major shareholder, Ms. Chen Xiangling, that she acquired a total of 9.2 million ordinary shares of the company in the public market on January 20, 2026. The average price per share was approximately HK$0.078, with the highest price being HK$0.078.
S HARBOURHOLD (01663) announced that the board of directors has been notified by the company's major shareholder, Ms. Chen Xiangling, that she has purchased a total of 9.2 million shares of the company's common stock on the open market on January 20, 2026. The average price per share was approximately HK$0.078, with the highest price being HK$0.078.
Related Articles
STAR SHINE HLDG (01440) spent HKD 486,000 on January 20 to repurchase 65,000 shares.
KUAISHOU-W (01024) spent HKD 29.9525 million on January 20 to repurchase 393,000 shares.
Jiangsu Hengrui Pharmaceuticals (01276): Injection SHR-9839 (sc) and injection HRS-4642 approved for drug clinical trials.
STAR SHINE HLDG (01440) spent HKD 486,000 on January 20 to repurchase 65,000 shares.
KUAISHOU-W (01024) spent HKD 29.9525 million on January 20 to repurchase 393,000 shares.
Jiangsu Hengrui Pharmaceuticals (01276): Injection SHR-9839 (sc) and injection HRS-4642 approved for drug clinical trials.
